Stablecoin Development Corp. (SDEV)
1.54
-0.45
(-22.61%)
USD |
NYAM |
Oct 09, 16:00
1.54
0.00 (0.00%)
After-Hours: 20:00
Stablecoin Development Enterprise Value : 70.79M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 70.79M |
| October 08, 2026 | 93.55M |
| October 07, 2026 | 133.52M |
| October 06, 2026 | 157.30M |
| October 05, 2026 | 192.21M |
| October 02, 2026 | 371.30M |
| October 01, 2026 | 178.04M |
| September 30, 2026 | 123.91M |
| September 29, 2026 | 158.31M |
| September 28, 2026 | 72.31M |
| September 25, 2026 | 68.26M |
| September 24, 2026 | 58.14M |
| September 23, 2026 | 49.54M |
| September 22, 2026 | 57.13M |
| September 21, 2026 | 43.47M |
| September 18, 2026 | 45.49M |
| September 17, 2026 | 35.43M |
| September 16, 2026 | 35.17M |
| September 15, 2026 | 36.31M |
| September 14, 2026 | 37.64M |
| September 11, 2026 | 38.07M |
| September 10, 2026 | 36.37M |
| September 09, 2026 | 37.21M |
| September 08, 2026 | 36.90M |
| September 04, 2026 | 37.90M |
| Date | Value |
|---|---|
| September 03, 2026 | 37.94M |
| September 02, 2026 | 36.34M |
| September 01, 2026 | 36.38M |
| August 31, 2026 | 40.70M |
| August 28, 2026 | 40.16M |
| August 27, 2026 | 42.40M |
| August 26, 2026 | 41.95M |
| August 25, 2026 | 45.49M |
| August 24, 2026 | 49.54M |
| August 21, 2026 | 50.55M |
| August 20, 2026 | 49.54M |
| August 19, 2026 | 43.47M |
| August 18, 2026 | 39.91M |
| August 17, 2026 | 42.46M |
| August 14, 2026 | 44.99M |
| August 13, 2026 | 43.47M |
| August 12, 2026 | 43.47M |
| August 11, 2026 | 45.49M |
| August 10, 2026 | 44.48M |
| August 07, 2026 | 44.99M |
| August 06, 2026 | 45.49M |
| August 05, 2026 | 44.99M |
| August 04, 2026 | 41.45M |
| August 03, 2026 | 49.03M |
| July 31, 2026 | 51.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.932B |
| Corcept Therapeutics, Inc. | 12.78B |
| Veru, Inc. | 18.84M |
| Johnson & Johnson | 657.89B |
| Eli Lilly & Co. | 1.156T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -41.07M |
| Revenue (Quarterly) | 2.206M |
| Total Expenses (Quarterly) | 43.28M |
| EPS Diluted (Quarterly) | -1.323 |
| Profit Margin (Quarterly) | -1.86K% |
| Earnings Yield | -48.09% |
| Normalized Earnings Yield | -137.18 |